Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 0.3 % Shares of NYSE BTX opened at $6.42 on Thursday. The stock has a market cap of $377.66 million, a PE ratio of […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Thursday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 0.3 % Shares of NYSE BTX opened at $6.42 on Thursday. The stock has a market cap of $377.66 million, a PE ratio of […]
